Abiopharma

Westlake Announces Acquisition of ACI Compounding Solutions Business

Gilead - European Commission Authorizes Twice-YearlyYeytuo® (Lenacapavir) for HIV Prevention

European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV Prevention

Celyad Oncology announces discontinuation of R&D activities

Smith+Nephew PLC Notification

CAPR Stockholders with Large Losses Should Contact Robbins LLP Before the Lead Plaintiff Deadline for Information About Leading the Capricor Therapeutics, Inc. Class Action Lawsuit

SPPI New Lead Plaintiff Deadline: Contact Robbins LLP for Information About Leading the Class Action Against SPPI

- Femasys Announces Pricing of $8.0 Million Underwritten Public Offering

Q & M Dental Group (Singapore) Limited - Announcement

NEOG Stockholders with Large Losses Should Contact Robbins LLP Before the Lead Plaintiff Deadline for Information About Leading the Neogen Corporation Class Action Lawsuit

Body and Mind Inc. Announces Agreement to Divest from New Jersey

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

New Form SCHEDULE 13D - Forian Inc. Filed: 2025-08-25 AccNo: 0000947871-25-000799 Size: 254 KB

New Form SCHEDULE 13D/A - Forian Inc. Filed: 2025-08-25 AccNo: 0000947871-25-000797 Size: 212 KB

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.